We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-2.75%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.1B
AUM Growth
+$273M
Cap. Flow
-$650M
Cap. Flow %
-4.61%
Top 10 Hldgs %
32.88%
Holding
703
New
–
Increased
221
Reduced
319
Closed
43

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$41.6M
2
NVDA icon
NVIDIA
NVDA
+$36M
3
ISRG icon
Intuitive Surgical
ISRG
+$33.8M
4
AMAT icon
Applied Materials
AMAT
+$32.4M
5
XP icon
XP
XP
+$31M

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$57.8M
2
JNJ icon
Johnson & Johnson
JNJ
+$54.9M
3
DHR icon
Danaher
DHR
+$41.9M
4
MSFT icon
Microsoft
MSFT
+$40.7M
5
LRCX icon
Lam Research
LRCX
+$37.4M

Sector Composition

Rank Sector Weight
1 Healthcare 26.08%
2 Technology 25.64%
3 Financials 11.81%
4 Industrials 7.9%
5 Materials 7.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IQV icon
51
IQVIA
IQV
$35.6B
$59.8M 0.42%
304,174
-11,685
-4% -$2.54M
RY icon
52
Royal Bank of Canada
RY
$291B
$59.8M 0.42%
681,162
+11,570
+2% +$1.08M
TRMB icon
53
Trimble
TRMB
$13B
$59.7M 0.42%
1,108,979
-44,285
-4% -$2.35M
APD icon
54
Air Products & Chemicals
APD
$65.2B
$58.7M 0.42%
207,219
-21,459
-9% -$6.29M
ALNY icon
55
Alnylam Pharmaceuticals
ALNY
$37.2B
$58.2M 0.41%
328,894
+10,000
+3% +$1.91M
INCY icon
56
Incyte
INCY
$23.7B
$57.4M 0.41%
994,338
+1,134
+0.1% +$71.5K
MDLZ icon
57
Mondelez International
MDLZ
$77.9B
$55.3M 0.39%
796,691
+65,256
+9% +$4.7M
AXP icon
58
American Express
AXP
$229B
$54.2M 0.38%
362,998
+14,683
+4% +$2.4M
COST icon
59
Costco
COST
$422B
$53.4M 0.38%
94,439
+36,000
+62% +$19.9M
ON icon
60
ON Semiconductor
ON
$34.7B
$52.9M 0.38%
569,567
-13,172
-2% -$1.28M
AWK icon
61
American Water Works
AWK
$26.3B
$50.4M 0.36%
407,043
+47,000
+13% +$6.59M
AMAT icon
62
Applied Materials
AMAT
$410B
$50.4M 0.36%
363,676
+225,807
+164% +$32.4M
LRCX icon
63
Lam Research
LRCX
$365B
$48.9M 0.35%
779,900
-569,200
-42% -$37.4M
LOW icon
64
Lowe's Companies
LOW
$119B
$48M 0.34%
231,148
-12,467
-5% -$2.8M
MCD icon
65
McDonald's
MCD
$192B
$48M 0.34%
182,022
-34,267
-16% -$9.77M
ADP icon
66
Automatic Data Processing
ADP
$102B
$47.2M 0.33%
196,058
-30,640
-14% -$7.47M
TJX icon
67
TJX Companies
TJX
$173B
$46.4M 0.33%
521,716
+43,883
+9% +$3.86M
MRNA icon
68
Moderna
MRNA
$22.1B
$45.7M 0.32%
442,360
+92,221
+26% +$10.3M
ANSS
69
DELISTED
Ansys
ANSS
$45.2M 0.32%
151,857
+4,297
+3% +$1.36M
META icon
70
Meta Platforms (Facebook)
META
$1.51T
$43.4M 0.31%
144,654
-28,192
-16% -$8.49M
SNPS icon
71
Synopsys
SNPS
$74.5B
$42.8M 0.3%
93,228
-26,368
-22% -$11.8M
NBIX icon
72
Neurocrine Biosciences
NBIX
$17.7B
$42.4M 0.3%
377,238
-63,178
-14% -$6.65M
TSM icon
73
TSMC
TSM
$2.07T
$41.5M 0.29%
477,252
+21,928
+5% +$2.07M
CMCSA icon
74
Comcast
CMCSA
$80.9B
$41.2M 0.29%
928,263
+87,915
+10% +$3.93M
MS icon
75
Morgan Stanley
MS
$337B
$40.8M 0.29%
499,812
+38,814
+8% +$3.37M
1 2
3
4 5

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q3 2023 Portfolio in Review

As of Q3 2023, Candriam SCA held 703 positions worth $14.1B, up 2% from $13.8B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Candriam SCA withdrew a net $650M in Q3 2023, closing 43 positions and reducing 319 holdings. Its most notable exit was Chinook Therapeutics, Inc. Common Stock, an estimated $31.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 31% a quarter earlier, followed by Technology and Financials.

Against the trend, Candriam SCA added an estimated $41.6M to Amgen.

  • Candriam SCA added most to Amgen in Q3 2023, an estimated $41.6M increase.
  • Candriam SCA's biggest Q3 2023 reduction was Visa, cutting an estimated $57.8M.
  • Candriam SCA fully exited Chinook Therapeutics, Inc. Common Stock in Q3 2023, selling an estimated $31.7M.
  • Candriam SCA's ten largest holdings make up 33% of its $14.1B portfolio in Q3 2023.
  • Candriam SCA opened 0 new positions and closed 43 in Q3 2023.
  • Candriam SCA's portfolio value rose 2% quarter-over-quarter to $14.1B.

Based on Candriam SCA's 13F filing for Q3 2023, filed 13 Nov 2023.